Laurent Seurin

Senior Director, Safety, Health & Environment AstraZeneca

Laurent Seurin, Senior Director of Safety, Health, and Environment (SHE) at AstraZeneca, overseeing the company’s Cambridge Operations. He plays a pivotal role in shaping AstraZeneca’s SHE strategy across UK facilities. His leadership is instrumental in integrating safety and environmental considerations into AstraZeneca’s operational framework, ensuring compliance with regulatory standards and fostering a culture of safety and sustainability within the organization.

Seminars

Tuesday 18th November 2025
Unlocking Value at the Intersection of EHS, Manufacturing Optimisation & Sustainability
8:00 am

As pharma and biotech organisations face pressure to increase productivity through AI, automation, and headcount reduction, there’s a growing need to connect the dots between EHS, continuous manufacturing, and sustainability. This closing panel will explore how aligning these areas can unlock operational value, enhance safety, and support long-term strategic goals.

Key Questions to Be Addressed:

  • How can EHS leaders play a strategic role in productivity and transformation programs driven by AI and continuous manufacturing?
  • What are the risks of overlooking EHS and sustainability in efforts to reduce FTEs and increase automation?
  • How can organisations practically align safety, efficiency, and sustainability goals to realise measurable benefits?
  • What leadership behaviours and structures are needed to bridge operational and EHS functions effectively?
Wednesday 19th November 2025
Beyond ‘Safety First’: Aligning EHS with the Mission to Deliver Life- Saving Medicine: Safety is Not the Goal, it is the Enabler
2:00 pm
  • Learn how to align safety culture with purposeful action: reframe safety as part of the drug development mission
  • Safety is foundational and when integrated properly, it empowers seamless, compliant, and high-performing operations
  • Consider treating safety as an operational strength to enable faster decision-making, smarter risk management, and ultimately, the ability to bring medicines to patients faster without compromising ethics or compliance
Laurent Seurin, Senior Director, Safety, Health and Environment (Cambridge Operations and UK SHE Lead), AstraZeneca